Simplex Trading
RNAC icon

Simplex Trading’s Cartesian Therapeutics RNAC Stock Holding History

Simplex Trading’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$209 – 9677
2023
Q3 		$0 Sell
7
-36
-84% -$1.2K ﹤0.01% 9648
2023
Q2 		$1K Sell
43
-1,129
-96% -$40.4K ﹤0.01% 8705
2023
Q1 		$48K Buy
+1,172
New +$55.1K ﹤0.01% 5970
2022
Q2 		– Sell
-269
Closed -$7.98K – 10913
2022
Q1 		$9K Sell
269
-709
-72% -$44.4K ﹤0.01% 8974
2021
Q4 		$95K Buy
978
+863
+750% +$92.8K ﹤0.01% 6337
2021
Q3 		$15K Sell
115
-11
-9% -$1.33K ﹤0.01% 8674
2021
Q2 		$15K Sell
126
-1,667
-93% -$199K ﹤0.01% 8831
2021
Q1 		$243K Buy
1,793
+1,437
+404% +$178K ﹤0.01% 4446
2020
Q4 		$0 Buy
356
+196
+123% +$17K ﹤0.01% 8951
2020
Q3 		$0 Sell
160
-3
-2% -$230 ﹤0.01% 8386
2020
Q2 		$13K Buy
163
+160
+5,333% +$14.5K ﹤0.01% 6504
2020
Q1 		$0 Buy
+3
New +$290 ﹤0.01% 8157
2019
Q2 		– Sell
-165
Closed -$11.2K – 7673
2019
Q1 		$11K Buy
165
+140
+560% +$8.87K ﹤0.01% 6108
2018
Q4 		$1K Sell
25
-24
-49% -$5.48K ﹤0.01% 6776
2018
Q3 		$22K Sell
49
-28
-36% -$11.2K ﹤0.01% 5886
2018
Q2 		$30K Buy
77
+40
+108% +$14.2K ﹤0.01% 5540
2018
Q1 		$11K Buy
+37
New +$10.5K ﹤0.01% 3968

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's RNAC Position: Q4 2023 in Review

Simplex Trading sold out of Cartesian Therapeutics (RNAC) in Q4 2023, closing a stake of 7 shares — an estimated $209 sold.

Simplex Trading first reported a position in RNAC in Q1 2018 and held it in 17 quarters. The position peaked at $243K in Q1 2021. 80 funds tracked by Wall St. Rank hold RNAC as of Q4 2023.

  • Simplex Trading reported no remaining Cartesian Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 7 Cartesian Therapeutics shares in Q4 2023, an estimated $209.
  • Simplex Trading first reported a position in Cartesian Therapeutics in Q1 2018 and held it in 17 quarters.
  • Simplex Trading's Cartesian Therapeutics position peaked at $243K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.